文献速递糖尿病

维生素C补充对2型糖尿病患者血糖控制与心血管危险因素影响的GRADE系统评价与荟萃分析

Effects of Vitamin C Supplementation on Glycemic Control and Cardiovascular Risk Factors in People With Type 2 Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis of Randomized Controlled Trials.
PubMed 文献 · Diabetes Care · 2021-01-01

结果显示维生素C可显著降低收缩压(中等证据质量)、HbA1c和舒张压(极低证据质量),但研究多为短期小样本,尚不能推荐作为治疗手段。

要点

  • 维生素C补充可显著降低2型糖尿病患者收缩压(中等证据质量)。
  • HbA1c和舒张压的改善证据质量极低,需谨慎解读。
  • 当前证据不足以推荐维生素C作为2型糖尿病治疗手段。

核心结论

  • 短期研究提示维生素C补充可能改善2型糖尿病患者的血糖控制和血压。
  • 在更大规模、长期、高质量试验确认前,不能推荐维生素C作为治疗手段。

研究设计与样本

  • 检索PubMed、Embase、Scopus、Cochrane Library及临床试验注册库至2020年9月8日。
  • 采用GRADE方法评估证据质量。

主要发现

  • 收缩压平均差异-6.27 mmHg(95%CI -9.60至-2.96,P=0.0002),证据质量中等。
  • HbA1c平均差异-0.54%(95%CI -0.90至-0.17,P=0.004),证据质量极低。
  • 舒张压平均差异-3.77 mmHg(95%CI -6.13至-1.42,P=0.002),证据质量极低。

临床怎么用

  • 目前不推荐将维生素C补充作为2型糖尿病的常规治疗。
  • 临床决策应基于更大规模长期试验的结果。

局限性

  • 纳入研究多为短期(<6个月)。
  • 研究样本量较小(n<100)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence suggests that vitamin C supplementation could be a potential therapy in type 2 diabetes. However, its effectiveness and evidence quality require further evaluation. PURPOSE: To investigate the efficacy of oral vitamin C supplementation in improving glycemic control, cardiovascular risk factors, and oxidative stress in people with type 2 diabetes. DATA SOURCES: Databases (PubMed, Embase, Scopus, Cochrane Library) and clinical trial registries were searched for randomized controlled trials up to 8 September 2020. STUDY SELECTION: Trials in adults with type 2 diabetes were included. Trials were excluded if supplements were not exclusive to vitamin C and if <2 weeks in duration. DATA EXTRACTION: Primary outcomes were HbA1c, glucose, cholesterol, triglycerides, and blood pressure (BP). Data were extracted for changes in outcomes between vitamin C and control groups. Evidence certainty was assessed using Grading of Recommendations, Assessment, Development, and Evaluation methods. DATA SYNTHESIS: Twenty-eight studies (N = 1,574 participants) were included in the review. Outcomes that changed to a statistically and clinically significant extent with vitamin C were systolic BP (mean difference -6.27 [95% CI -9.60, -2.96] mmHg; P = 0.0002), with moderate evidence certainty, and HbA1c (-0.54% [-0.90, -0.17]; P = 0.004) and diastolic BP (-3.77 [-6.13, -1.42] mmHg; P = 0.002) with very low evidence certainty. LIMITATIONS: Studies were predominantly short term (<6 months) with a small number of participants (n < 100). CONCLUSIONS: While evidence from short-term studies suggests that vitamin C supplementation may improve glycemic control and BP in people with type 2 diabetes, vitamin C supplementation cannot currently be recommended as a therapy until larger, long-term, and high-quality trials confirm these findings.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Mason SA, Keske MA, Wadley GD, et al. Effects of Vitamin C Supplementation on Glycemic Control and Cardiovascular Risk Factors in People With Type 2 Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care. 2021. PMID: 33472962. doi:10.2337/dc20-1893

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。